Displaying 131 - 135 of 225
Thu 17 September 2015
The National Institute for Health and Care Excellence (NICE) has today (Thursday, 17th September) announced it will not allow advanced pancreatic cancer patients in England routine access to the life-extending drug Abraxane on the NHS.Read More about 'Last hope dashed for access to life-extending pancreatic cancer drug on the NHS in England'
Fri 11 September 2015
Research findings into the use of an anti-diabetic drug that can be used to ‘suffocate’ pancreatic cancer stem cells have been widely reported in the media today. Here's our comment.Read More about 'Anti-diabetic drug to 'suffocate' pancreatic cancer cells is promising'
Fri 04 September 2015
NHS England has today (Friday, 4th September) announced that the life-extending drug Abraxane will no longer be available to people with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF) from 4th November 2015.Read More about 'Hundreds of patients denied life-extending treatment'
Thu 20 August 2015
The Information Services Division (ISD) Scotland has this week released data showing trends in the likely number of cases of different cancer types over a 25 year period up until 2027. Here's our comment.Read More about 'Scottish incidence predictions for pancreatic cancer'
Tue 04 August 2015
A ComRes survey of over 2,000 people, commissioned by Pancreatic Cancer UK, found that almost three quarters could not name unprompted any symptoms of the disease, which include tummy pain, weight loss, yellow skin or eyes or itchy skin and oily floating poo.Read More about 'Three quarters of UK adults can't name even one pancreatic cancer symptom'